financetom
Business
financetom
/
Business
/
Vivani Medical Insider Bought Shares Worth $2,400,001, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vivani Medical Insider Bought Shares Worth $2,400,001, According to a Recent SEC Filing
Sep 17, 2025 8:27 AM

09:50 AM EDT, 09/17/2025 (MT Newswires) -- Gregg Williams, 10% Owner, Director, on September 15, 2025, executed a purchase for 2,068,453 shares in Vivani Medical ( VANI ) for $2,400,001. Following the Form 4 filing with the SEC, Williams has control over a total of 20,708,548 common shares of the company, with 4,799,200 shares held directly and 15,909,348 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1266806/000175392625001511/xslF345X05/primary_doc.xml

Price: 1.34, Change: +0.13, Percent Change: +10.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
dynaCERT Received Final Verra Approval of its Carbon Credit Methodology; Jumped 31% and Hit 52 Week Highs on Friday
dynaCERT Received Final Verra Approval of its Carbon Credit Methodology; Jumped 31% and Hit 52 Week Highs on Friday
Oct 7, 2024
06:45 AM EDT, 10/07/2024 (MT Newswires) -- dynaCERT (DYA.TO), which jumped more than 30% and hit fresh 52 week highs last Friday, over the weekend announced that it has received the final Verra approval of its Carbon Credit Methodology. In a statement dynaCert said this Verra-approved methodology marks a significant milestone in the company's ongoing business evolution, as it underscores...
Pfizer Eyed By Starboard for Shareholder Rights Campaign
Pfizer Eyed By Starboard for Shareholder Rights Campaign
Oct 7, 2024
06:44 AM EDT, 10/07/2024 (MT Newswires) -- Pfizer ( PFE ) may become the target of a shareholder campaign led by Starboard Value, which has taken a $1 billion stake in the company, multiple news outlets reported Sunday. Reuters reported that Starboard, an activist investment advisory firm, wants to improve Pfizer's ( PFE ) performance and has already approached former...
CAMP4 Therapeutics seeks up to $283 mln valuation in US IPO
CAMP4 Therapeutics seeks up to $283 mln valuation in US IPO
Oct 7, 2024
Oct 7 (Reuters) - CAMP4 Therapeutics, a biopharmaceutical company backed by healthcare giant Kaiser Permanente, said on Monday it was targeting a valuation of up to $283 million in its initial public offering in the United States. The company will join a pack of biotech firms that have listed their shares recently as a long-awaited policy-easing cycle begins. Startups are...
CAMP4 Therapeutics seeks up to $283 million valuation in US IPO
CAMP4 Therapeutics seeks up to $283 million valuation in US IPO
Oct 7, 2024
(Reuters) - CAMP4 Therapeutics, a biopharmaceutical company backed by healthcare giant Kaiser Permanente, said on Monday it was targeting a valuation of up to $283 million in its initial public offering in the United States. The company will join a pack of biotech firms that have listed their shares recently as a long-awaited policy-easing cycle begins. Startups are also looking...
Copyright 2023-2026 - www.financetom.com All Rights Reserved